Diagnosis and Treatment for Early Breast Carcinoma_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

Wang Qi , Li Wenping

Corresponding?author：

Keywords：

乳腺癌; 早期診斷; 治療

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： Wang Qi,Li Wenping. Diagnosis and Treatment for Early Breast Carcinoma. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2004, 11(1): 9-11. doi: Copy

1.	Fentiman IS. The dilemma of in situ carcinoma of the breast [J] . Int J Clin Pract， 2001; 55(10)∶680.
2.	Melvin JS. Ductal carcinoma in situ of the breast: the treatment controversy [J]. Breast， 2003; 12(S1)∶8.
3.	許娟，王頎，張安秦，等. 組織學早期乳腺癌的臨床診斷 [J]. 嶺南現代外科， 2003； 3（3）∶28.
4.	Claus EB, Stowe M, Carter D. Breast carcinoma in situ: risk factors and screening patterns [J]. J Natl Cancer Inst， 2001; 93(23)∶1811.
5.	Fisher ER, Dignam J, TanChiu E, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eightyear update of Protocol B17: intraductal carcinoma [J]. Cancer, 1999; 86(3)∶429.
6.	Morrow M, Strom EA, Bassett LW, et al. Standard for the management of ductal carcinoma in situ of the breast (DCIS) [J]. CA Cancer J Clin, 2002; 52(5)∶256.
7.	Bordeleau L, Rakovitch E, Naimark DM, et al. A comparison of four treatment strategies for ductal carcinoma in situ using decision analysis [J]. Cancer, 2001; 92(1)∶23.
8.	Boland GP, Knox WF, Bundred NJ. Molecular markers and therapeutic targets in ductal carcinoma in situ [J]. Microsc Res Tech, 2002; 59(1)∶3.
9.	張亞偉, 沈坤煒, 相加慶, 等. 乳腺導管內癌52例分析 [J]. 中華腫瘤雜志, 1999; 21(5)∶391.
10.	王頎，張安秦，施軍濤. 乳管內隆起性病變的乳管內視鏡下特征和分型 [J]. 中華普通外科雜志, 2002; 17(1)∶58.
11.	王頎主編. 乳管內視鏡檢查彩色圖譜 [M]. 第1版. 美國. 紐約: 國際中華科學技術出版社, 2002∶10～13.
12.	Ikeda DM, Birdwell RL, Daniel BL. Potential role of magnetic resonance imaging and other modalities in ductal carcinoma in situ detection [J]. Magn Reson Imaging Clin N Am, 2001; 9(2)∶345.
13.	Cangiarella J, Waisman J, Symmans WF, et al. Mammotome core biopsy for mammary microcalcification: analysis of 160 biopsies from 142 women with surgical and radiologic followup [J]. Cancer, 2001; 91(1)∶173.
14.	郭慶祿, 葉志球, 劉慶余. X線攝影、彩色多普勒超聲和立體定位穿刺對早期乳腺癌的診斷價值 [J]. 中華放射學雜志, 2001; 35(10)∶782.
15.	Kestin LL, Goldstein NS, Martinez AA, et al. Mammographically detected ductal carcinoma in situ treated with conservative surgery with or without radiation therapy: patterns of failure and 10year results [J]. Ann Surg, 2000; 231(2)∶235.
16.	Chan KC, Knox WF, Sinha G, et al. Extent of excision margin width required in breast conserving surgery for ductal carcinoma in situ [J]. Cancer, 2001; 91(1)∶9.
17.	Pendas S, Dauway E, Giuliano R, et al. Sentinel node biopsy in ductal carcinoma in situ patients [J]. Ann Surg Oncol, 2000; 7(1)∶15.
18.	Hiram S. Sentinel lymph node biopsy for ductal carcinoma in situ [J]. Seminars in Breast Disease, 2002; 5(2)∶88.
19.	Cote RJ, Peterson HF, Chaiwun B, et al. Role of immunohistochemical detection of lymphnode metastases in management of breast cancer. International Breast Cancer Study Group [J]. Lancet, 1999; 354(9182)∶896.
20.	Fisher B, Dignam J, Wolmark N, et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B24 randomised controlled trial [J]. Lancet, 1999; 353(9169)∶1993.
21.	Wickerham L. Tamoxifenan update on current data and where it can now be used [J]. Breast Cancer Res Treat, 2002; 75 Suppl 1∶S7.
22.	Miller NA, Chapman JA, Fish EB, et al. In situ duct carcinoma of the breast: clinical and histopathologic factors and association with recurrent carcinoma [J]. Breast J, 2001; 7(5)∶292.
23.	Mirza NQ, Vlastos G, Meric F, et al. Ductal carcinomainsitu: longterm results of breastconserving therapy [J]. Ann Surg Oncol, 2000; 7(9)∶656.
24.	Stallard S, Hole DA, Purushotham AD, et al. Ductal carcinoma in situ of the breastamong factors predicting for recurrence, distance from the nipple is important [J]. Eur J Surg Oncol, 2001; 27(4)∶373.
25.	Solin LJ, Fourquet A, Vicini FA, et al. Salvage treatment for local recurrence after breastconserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast [J]. Cancer, 2001; 91(6)∶1090.
26.	Vicini FA, Recht A. Age at diagnosis and outcome for women with ductal carcinomainsitu of the breast: a critical review of the literature [J]. J Clin Oncol, 2002; 20(11)∶2736.
27.	Harris EE, Schultz DJ, Peters CA, et al. Relationship of family history and outcome after breast conservation therapy in women with ductal carcinoma in situ of the breast [J]. Int J Radiat Oncol Biol Phys, 2000; 48(4)∶933.
28.	de Mascarel I, MacGrogan G, MathoulinPelissier S, et al. Breast ductal carcinoma in situ with microinvasion: a definition supported by a longterm study of 1 248 serially sectioned ductal carcinomas [J]. Cancer, 2002; 94(8)∶2134.

1. Fentiman IS. The dilemma of in situ carcinoma of the breast [J] . Int J Clin Pract， 2001; 55(10)∶680.
2. Melvin JS. Ductal carcinoma in situ of the breast: the treatment controversy [J]. Breast， 2003; 12(S1)∶8.
3. 許娟，王頎，張安秦，等. 組織學早期乳腺癌的臨床診斷 [J]. 嶺南現代外科， 2003； 3（3）∶28.
4. Claus EB, Stowe M, Carter D. Breast carcinoma in situ: risk factors and screening patterns [J]. J Natl Cancer Inst， 2001; 93(23)∶1811.
5. Fisher ER, Dignam J, TanChiu E, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eightyear update of Protocol B17: intraductal carcinoma [J]. Cancer, 1999; 86(3)∶429.
6. Morrow M, Strom EA, Bassett LW, et al. Standard for the management of ductal carcinoma in situ of the breast (DCIS) [J]. CA Cancer J Clin, 2002; 52(5)∶256.
7. Bordeleau L, Rakovitch E, Naimark DM, et al. A comparison of four treatment strategies for ductal carcinoma in situ using decision analysis [J]. Cancer, 2001; 92(1)∶23.
8. Boland GP, Knox WF, Bundred NJ. Molecular markers and therapeutic targets in ductal carcinoma in situ [J]. Microsc Res Tech, 2002; 59(1)∶3.
9. 張亞偉, 沈坤煒, 相加慶, 等. 乳腺導管內癌52例分析 [J]. 中華腫瘤雜志, 1999; 21(5)∶391.
10. 王頎，張安秦，施軍濤. 乳管內隆起性病變的乳管內視鏡下特征和分型 [J]. 中華普通外科雜志, 2002; 17(1)∶58.
11. 王頎主編. 乳管內視鏡檢查彩色圖譜 [M]. 第1版. 美國. 紐約: 國際中華科學技術出版社, 2002∶10～13.
12. Ikeda DM, Birdwell RL, Daniel BL. Potential role of magnetic resonance imaging and other modalities in ductal carcinoma in situ detection [J]. Magn Reson Imaging Clin N Am, 2001; 9(2)∶345.
13. Cangiarella J, Waisman J, Symmans WF, et al. Mammotome core biopsy for mammary microcalcification: analysis of 160 biopsies from 142 women with surgical and radiologic followup [J]. Cancer, 2001; 91(1)∶173.
14. 郭慶祿, 葉志球, 劉慶余. X線攝影、彩色多普勒超聲和立體定位穿刺對早期乳腺癌的診斷價值 [J]. 中華放射學雜志, 2001; 35(10)∶782.
15. Kestin LL, Goldstein NS, Martinez AA, et al. Mammographically detected ductal carcinoma in situ treated with conservative surgery with or without radiation therapy: patterns of failure and 10year results [J]. Ann Surg, 2000; 231(2)∶235.
16. Chan KC, Knox WF, Sinha G, et al. Extent of excision margin width required in breast conserving surgery for ductal carcinoma in situ [J]. Cancer, 2001; 91(1)∶9.
17. Pendas S, Dauway E, Giuliano R, et al. Sentinel node biopsy in ductal carcinoma in situ patients [J]. Ann Surg Oncol, 2000; 7(1)∶15.
18. Hiram S. Sentinel lymph node biopsy for ductal carcinoma in situ [J]. Seminars in Breast Disease, 2002; 5(2)∶88.
19. Cote RJ, Peterson HF, Chaiwun B, et al. Role of immunohistochemical detection of lymphnode metastases in management of breast cancer. International Breast Cancer Study Group [J]. Lancet, 1999; 354(9182)∶896.
20. Fisher B, Dignam J, Wolmark N, et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B24 randomised controlled trial [J]. Lancet, 1999; 353(9169)∶1993.
21. Wickerham L. Tamoxifenan update on current data and where it can now be used [J]. Breast Cancer Res Treat, 2002; 75 Suppl 1∶S7.
22. Miller NA, Chapman JA, Fish EB, et al. In situ duct carcinoma of the breast: clinical and histopathologic factors and association with recurrent carcinoma [J]. Breast J, 2001; 7(5)∶292.
23. Mirza NQ, Vlastos G, Meric F, et al. Ductal carcinomainsitu: longterm results of breastconserving therapy [J]. Ann Surg Oncol, 2000; 7(9)∶656.
24. Stallard S, Hole DA, Purushotham AD, et al. Ductal carcinoma in situ of the breastamong factors predicting for recurrence, distance from the nipple is important [J]. Eur J Surg Oncol, 2001; 27(4)∶373.
25. Solin LJ, Fourquet A, Vicini FA, et al. Salvage treatment for local recurrence after breastconserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast [J]. Cancer, 2001; 91(6)∶1090.
26. Vicini FA, Recht A. Age at diagnosis and outcome for women with ductal carcinomainsitu of the breast: a critical review of the literature [J]. J Clin Oncol, 2002; 20(11)∶2736.
27. Harris EE, Schultz DJ, Peters CA, et al. Relationship of family history and outcome after breast conservation therapy in women with ductal carcinoma in situ of the breast [J]. Int J Radiat Oncol Biol Phys, 2000; 48(4)∶933.
28. de Mascarel I, MacGrogan G, MathoulinPelissier S, et al. Breast ductal carcinoma in situ with microinvasion: a definition supported by a longterm study of 1 248 serially sectioned ductal carcinomas [J]. Cancer, 2002; 94(8)∶2134.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Diagnosis and Treatment for Early Breast Carcinoma

Abstract Full text Figures/Tables Video References Cited by

Format

Content